Patient-Reported Outcome Measures in Cardiac Rehabilitation: Impact on Health Care (PROM_R)

July 30, 2024 updated by: José Manuel Afonso Moreira

Patient-Reported Outcome Measures and Quality of Life in Cardiac Rehabilitation: Impact on Health Care

Cardiac Rehabilitation (CR) programs are a multidisciplinary process aimed at patient recovery after an acute cardiovascular event or with chronic heart disease, reducing mortality and morbidity, optimising functional capacity and improving quality of life. The aim is to maintain or recover the patient's clinical, physical and psychosocial condition, slowing down or halting the progression of the underlying disease process. It is based on the practice of personalized physical exercise and the adaptation of behaviours towards a healthier lifestyle, ensuring the reduction and control of risk factors. It is considered a cost-effective intervention that is explicitly and formally recommended by the most diverse and important scientific societies. Through the partnership and collaboration between the various health institutions and the academy, the CR program will take place on an outpatient basis, in a supervised manner, starting after risk stratification with a stress test and respective clinical assessment by a cardiologist. The coordinator of the CR program will be a cardiologist, and the entire multidisciplinary team will be responsible for effectiveness and safety, as well as patient assessment and progress.

Study Overview

Detailed Description

The outpatient CR program is designed for a group of participants who have had a cardiac event, based on the American College of Sports Medicine's Guidelines for Exercise Testing and Prescription, consisting of two exercise sessions/week. The sessions are supervised by a healthcare professional specialising in cardiac rehabilitation, and the participant's haemodynamic status is monitored continuously using scales and electronic equipment. PROMs will be applied before and after the program.

Study Type

Interventional

Enrollment (Actual)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lisbon, Portugal
        • National School of Public Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult (> 18 years);
  • Low-moderate risk for physical exercise;
  • After a cardiac event;
  • Have signed an informed consent form.

Exclusion Criteria:

  • Physical or mental limitation to carry out an exercise programme;
  • Uncontrolled arrhythmia;
  • Severe chronic obstructive pulmonary disease;
  • Uncontrolled hypertension;
  • Symptomatic peripheral arterial disease;
  • Unstable angina;
  • Uncontrolled diabetes;
  • Acute pulmonary oedema in the last 12 hours;
  • Those who refuse to participate.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cardiac Rehabilitation intervention
Outpatient intervention with participants after a cardiac event who fulfil the inclusion criteria.

The program is multidisciplinary with the following components:

  • Medical assessment
  • Physical training and counselling on physical activity
  • Identification and control of risk factors
  • Nutritional assessment and counselling
  • Psychological assessment and intervention
  • Education and information

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EQ5D-5L: Health-related quality of life
Time Frame: Before the intervention and up to 8 weeks.
The EQ5D makes it possible to assess quality of life in a given pathology in the general population, presented in different domains. The visual analogue scale of this questionnaire has a score of 0-100. Higher scores mean a better result.
Before the intervention and up to 8 weeks.
HADS: Anxiety and depression
Time Frame: Before the intervention and up to 8 weeks.
Participants' anxiety and worries are also assessed. Mood disorders, weakness, worry, stress, and depression are common psychological repercussions for patients after a cardiac event, which can trigger hyperventilation reactions. This type of common reaction to emotional extremes such as fear, anxiety, or stress in participants can have a direct impact on involvement in CR programs. This questionnaire is made up of 14 questions. Lower scores mean a better result.
Before the intervention and up to 8 weeks.
BREQ-2: Behavioural Regulations in Exercise Questionnaire
Time Frame: Before the intervention and up to 8 weeks.
Assessment of the different aspects of motivational regulation for exercise. It is a questionnaire that evaluates and represents the differences in the ways in which people's behaviour can be regulated and how these differences are experienced.
Before the intervention and up to 8 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate
Time Frame: Before, during and up to 8 weeks of the program.
Heart rate (bpm)
Before, during and up to 8 weeks of the program.
Blood pressure
Time Frame: Before, during and up to 8 weeks of the program.
Blood pressure (mmHg)
Before, during and up to 8 weeks of the program.
Peripheral oxygen saturation
Time Frame: Before, during and up to 8 weeks of the program.
Peripheral oxygen saturation (%)
Before, during and up to 8 weeks of the program.
Exercise Capacity
Time Frame: During and up to 8 weeks of the program.
Borg scale- score 0-10. Higher values mean greater respiratory effort.
During and up to 8 weeks of the program.
Weight
Time Frame: Before the intervention and up to 8 weeks.
Weight (Kg)
Before the intervention and up to 8 weeks.
Abdominal perimeter
Time Frame: Before the intervention and up to 8 weeks.
Abdominal perimeter (cm)
Before the intervention and up to 8 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2023

Primary Completion (Actual)

March 1, 2024

Study Completion (Actual)

April 1, 2024

Study Registration Dates

First Submitted

August 24, 2023

First Submitted That Met QC Criteria

September 6, 2023

First Posted (Actual)

September 11, 2023

Study Record Updates

Last Update Posted (Actual)

July 31, 2024

Last Update Submitted That Met QC Criteria

July 30, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • National School Public Health

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on Cardiac rehabilitation program (PROMs)

Subscribe